301 related articles for article (PubMed ID: 36277689)
1. Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort.
Viecceli C; Mattos ACV; Costa MCB; de Melo RB; Rodrigues TDC; Czepielewski MA
Front Endocrinol (Lausanne); 2022; 13():1017331. PubMed ID: 36277689
[TBL] [Abstract][Full Text] [Related]
2. Ketoconazole as second-line treatment for Cushing's disease after transsphenoidal surgery: systematic review and meta-analysis.
Viecceli C; Mattos ACV; Hirakata VN; Garcia SP; Rodrigues TDC; Czepielewski MA
Front Endocrinol (Lausanne); 2023; 14():1145775. PubMed ID: 37223017
[TBL] [Abstract][Full Text] [Related]
3. Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease.
Castinetti F; Morange I; Jaquet P; Conte-Devolx B; Brue T
Eur J Endocrinol; 2008 Jan; 158(1):91-9. PubMed ID: 18166822
[TBL] [Abstract][Full Text] [Related]
4. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
5. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.
Patil CG; Prevedello DM; Lad SP; Vance ML; Thorner MO; Katznelson L; Laws ER
J Clin Endocrinol Metab; 2008 Feb; 93(2):358-62. PubMed ID: 18056770
[TBL] [Abstract][Full Text] [Related]
6. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
Engelhardt D; Weber MM
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease.
Vilar L; Naves LA; Azevedo MF; Arruda MJ; Arahata CM; Moura E Silva L; Agra R; Pontes L; Montenegro L; Albuquerque JL; Canadas V
Pituitary; 2010 Jun; 13(2):123-9. PubMed ID: 19943118
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-dependent Cushing's syndrome in older people: presentation of five cases and therapeutical use of ketoconazole.
Berwaerts JJ; Verhelst JA; Verhaert GC; Verhaegen AA; Abs RE
J Am Geriatr Soc; 1998 Jul; 46(7):880-4. PubMed ID: 9670876
[TBL] [Abstract][Full Text] [Related]
9. Cushing's disease: adrenal steroidogenesis inhibitors.
Pivonello R; Simeoli C; Di Paola N; Colao A
Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease.
Feelders RA; Fleseriu M; Kadioglu P; Bex M; González-Devia D; Boguszewski CL; Yavuz DG; Patino H; Pedroncelli AM; Maamari R; Chattopadhyay A; Biller BMK; Pivonello R
Front Endocrinol (Lausanne); 2023; 14():1165681. PubMed ID: 37876540
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
[TBL] [Abstract][Full Text] [Related]
12. Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease.
van den Bosch OF; Stades AM; Zelissen PM
Clin Endocrinol (Oxf); 2014 Feb; 80(2):184-90. PubMed ID: 23841642
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole?
Barbot M; Albiger N; Ceccato F; Zilio M; Frigo AC; Denaro L; Mantero F; Scaroni C
Pituitary; 2014 Apr; 17(2):109-17. PubMed ID: 23468128
[TBL] [Abstract][Full Text] [Related]
14. Results of gamma knife surgery for Cushing's disease.
Sheehan JP; Xu Z; Salvetti DJ; Schmitt PJ; Vance ML
J Neurosurg; 2013 Dec; 119(6):1486-92. PubMed ID: 23930850
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial.
Fleseriu M; Pivonello R; Elenkova A; Salvatori R; Auchus RJ; Feelders RA; Geer EB; Greenman Y; Witek P; Cohen F; Biller BMK
Lancet Diabetes Endocrinol; 2019 Nov; 7(11):855-865. PubMed ID: 31542384
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas.
Cannavò S; Almoto B; Dall'Asta C; Corsello S; Lovicu RM; De Menis E; Trimarchi F; Ambrosi B
Eur J Endocrinol; 2003 Sep; 149(3):195-200. PubMed ID: 12943521
[TBL] [Abstract][Full Text] [Related]
17. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
Lau D; Rutledge C; Aghi MK
Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
[TBL] [Abstract][Full Text] [Related]
18. Drugs in the medical treatment of Cushing's syndrome.
Schteingart DE
Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.
Pivonello R; Fleseriu M; Newell-Price J; Bertagna X; Findling J; Shimatsu A; Gu F; Auchus R; Leelawattana R; Lee EJ; Kim JH; Lacroix A; Laplanche A; O'Connell P; Tauchmanova L; Pedroncelli AM; Biller BMK;
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):748-761. PubMed ID: 32730798
[TBL] [Abstract][Full Text] [Related]
20. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).
Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Timmers HJ; Grotenhuis JA; Hermus AR
Clin Endocrinol (Oxf); 2009 Feb; 70(2):274-80. PubMed ID: 18616702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
